Literature DB >> 25140557

Detection of osseous metastasis by 18F-NaF/18F-FDG PET/CT versus CT alone.

Srinath C Sampath1, Srihari C Sampath, Camila Mosci, Amelie M Lutz, Juergen K Willmann, Erik S Mittra, Sanjiv S Gambhir, Andrei Iagaru.   

Abstract

PURPOSE: Sodium fluoride PET (18F-NaF) has recently reemerged as a valuable method for detection of osseous metastasis, with recent work highlighting the potential of coadministered 18F-NaF and 18F-FDG PET/CT in a single combined imaging examination. We further examined the potential of such combined examinations by comparing dual tracer 18F-NaF18/F-FDG PET/CT with CT alone for detection of osseous metastasis. PATIENTS AND METHODS: Seventy-five participants with biopsy-proven malignancy were consecutively enrolled from a single center and underwent combined 18F-NaF/18F-FDG PET/CT and diagnostic CT scans. PET/CT as well as CT only images were reviewed in blinded fashion and compared with the results of clinical, imaging, or histological follow-up as a truth standard.
RESULTS: Sensitivity of the combined 18F-NaF/18F-FDG PET/CT was higher than that of CT alone (97.4% vs 66.7%). CT and 18F-NaF/18F-FDG PET/CT were concordant in 73% of studies. Of 20 discordant cases, 18F-NaF/18F-FDG PET/CT was correct in 19 (95%). Three cases were interpreted concordantly but incorrectly, and all 3 were false positives. A single case of osseous metastasis was detected by CT alone, but not by 18F-NaF/18F-FDG PET/CT.
CONCLUSIONS: Combined 18F-NaF/18F-FDG PET/CT outperforms CT alone and is highly sensitive and specific for detection of osseous metastases. The concordantly interpreted false-positive cases demonstrate the difficulty of distinguishing degenerative from malignant disease, whereas the single case of metastasis seen on CT but not PET highlights the need for careful review of CT images in multimodality studies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25140557     DOI: 10.1097/RLU.0000000000000560

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  8 in total

1.  Simultaneous PET/MRI in the Evaluation of Breast and Prostate Cancer Using Combined Na[18F] F and [18F]FDG: a Focus on Skeletal Lesions.

Authors:  Ida Sonni; Ryogo Minamimoto; Lucia Baratto; Sanjiv S Gambhir; Andreas M Loening; Shreyas S Vasanawala; Andrei Iagaru
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

Review 2.  Prostate Cancer Imaging with Novel PET Tracers.

Authors:  Liza Lindenberg; Peter Choyke; William Dahut
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

3.  Advantages of 18F FDG-PET/CT over Conventional Staging for Sarcoma Patients.

Authors:  Zsuzsanna Németh; Katalin Boér; Katalin Borbély
Journal:  Pathol Oncol Res       Date:  2017-10-09       Impact factor: 3.201

4.  A First Report on [18F]FPRGD2 PET/CT Imaging in Multiple Myeloma.

Authors:  Nadia Withofs; François Cousin; Bernard De Prijck; Christophe Bonnet; Roland Hustinx; Sanjiv S Gambhir; Yves Beguin; Jo Caers
Journal:  Contrast Media Mol Imaging       Date:  2017-07-27       Impact factor: 3.161

5.  18-Fluoride labeled sodium fluoride positron emission tomography with computer tomography: the impact of pretreatment staging in intermediate- and high-risk prostate cancer.

Authors:  Simon Jd Harley; Richard Hoffmann; Dylan Bartholomeusz; Peter Sutherland; Barry Chatterton; Michael Kitchener; Prab Takhar; Chris Tsopelas; Andrew Fuller; Richard Wells; Raj Singh-Rai; John Bolt
Journal:  Prostate Int       Date:  2017-12-27

6.  Comparison of PET/CT and MRI in the Diagnosis of Bone Metastasis in Prostate Cancer Patients: A Network Analysis of Diagnostic Studies.

Authors:  Fanxiao Liu; Jinlei Dong; Yelong Shen; Canhua Yun; Ruixiao Wang; Ganggang Wang; Jiyang Tan; Tao Wang; Qun Yao; Bomin Wang; Lianxin Li; Jingyi Mi; Dongsheng Zhou; Fei Xiong
Journal:  Front Oncol       Date:  2021-10-04       Impact factor: 6.244

Review 7.  Comparison of 18 F-NaF Imaging, 99m Tc-MDP Scintigraphy, and 18 F-FDG for Detecting Bone Metastases.

Authors:  Habibollah Dadgar; Nasim Norouzbeigi; Narges Jokar; Jafar Zareizadeh; Ali Gholamrezanezhad; Hojjat Ahmadzadehfar; Moloud Abbaszadeh; Majid Assadi
Journal:  World J Nucl Med       Date:  2022-04-30

Review 8.  Oligometastases in prostate cancer: restaging stage IV cancers and new radiotherapy options.

Authors:  Antonio José Conde Moreno; Carlos Ferrer Albiach; Rodrigo Muelas Soria; Verónica González Vidal; Raquel García Gómez; María Albert Antequera
Journal:  Radiat Oncol       Date:  2014-12-11       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.